SCHEMBL7964122

SCHEMBL7964122

Cc1ccc(N2CCN(CCCc3[nH]nc4c3CCC4)CC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HTR7 P34969 3/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SIGMAR1 Q99720 2/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
SLC27A1 Q6PCB7 1/20 0.39
KCNH2 Q12809 2/20 0.38
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
DRD3 P35462 1/20 0.38
ADRA2A P08913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5775439 0.98 MAPT (0.45) MAPTNPSR1HTR7ALDH1A1MEN1
SCHEMBL5775029 0.97 MAPT (0.44) MAPTNPSR1HTR7ALDH1A1MEN1
Fumaric Acid SCHEMBL5770886 0.89 SLC27A1 (0.41) MAPTNPSR1HTR7ALDH1A1POLB
Maleic Acid SCHEMBL5770880 0.89 SLC27A1 (0.41) MAPTNPSR1HTR7ALDH1A1POLB
SCHEMBL5776684 0.88 SIGMAR1 (0.53) HTR7KMT2ASIGMAR1KCNH2DRD2
Hydrochloric Acid SCHEMBL5770744 0.87 SIGMAR1 (0.51) HTR7KDM4ESIGMAR1DRD2DRD4
Hydrochloric Acid SCHEMBL5775839 0.86 HTR1A (0.45) SIGMAR1DRD2DRD4DRD3
SCHEMBL5774541 0.86 HTR1A (0.49) SIGMAR1DRD2DRD4DRD3
SCHEMBL5772229 0.86 SIGMAR1 (0.52) HTR7KDM4ESIGMAR1DRD2DRD4
SCHEMBL5772832 0.86 SIGMAR1 (0.53) HTR7SIGMAR1KCNH2DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed